Literature DB >> 26872871

Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren's syndrome successfully treated with mizoribine.

Yasumori Izumi1,2, Kenjiro Nakaoka1,2, Masatsugu Kamata2, Nozomi Iwanaga1, Shunsuke Imadachi2, Hirokazu Kurohama3, Masahiro Ito3, Kiyoshi Migita2.   

Abstract

A 64-year-old woman with leg edema was diagnosed with protein-losing gastroenteropathy and Sjögren's syndrome. Central venous nutrition led to infection of her catheter, ascites, and deep vein thrombosis. Following successful treatment of these conditions with antibiotics and anticoagulants, she was treated unsuccessfully with prednisolone and steroid pulse therapy. Mizoribine add-on markedly reduced edema and normalized serum albumin. This is the first report of a steroid-resistant protein-losing gastroenteropathy patient with Sjögren's syndrome successfully treated with mizoribine.

Entities:  

Keywords:  Mizoribine; Sjögren’s syndrome; Steroid-resistant PLGE

Mesh:

Substances:

Year:  2016        PMID: 26872871     DOI: 10.3109/14397595.2016.1145570

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Sjögren's syndrome concurrent with protein-losing gastroenteropathy with secondary systemic capillary leak syndrome : A case report.

Authors:  Kei Watanabe; Shinichiro Murakami; Masahiro Misago; Mai Yoshikawa; Daisuke Tamai; Shinichiro Nakao; Takato Ueoka; Mototoshi Ito; Yasuhisa Shinomura; Nobuyuki Kajiwara
Journal:  Clin Case Rep       Date:  2018-07-31

2.  Protein-losing gastroenteropathy with severe hypoalbuminemia associated with Sjögren's syndrome: A case report and review of the literature.

Authors:  Tetsuya Akaishi; Ken Yasaka; Michiaki Abe; Hiroshi Fujii; Mika Watanabe; Tsuyoshi Shirai; Kota Ishizawa; Shin Takayama; Yutaka Kagaya; Hideo Harigae; Tadashi Ishii
Journal:  J Gen Fam Med       Date:  2019-10-16

3.  A case report of Sjögren's syndrome associated with protein-losing gastroenteropathy successfully treated with methylprednisolone.

Authors:  Xiaoming Li; Fan Lin; Ziyu Wu; Yan Chen; Pengli Zhu
Journal:  J Int Med Res       Date:  2019-10-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.